caa a22 4500 469079673 CHVBK 20180323132946.0 cr unu---uuuuu 170328e19920501xx s 000 0 eng 10.1007/BF00168940 doi (NATIONALLICENCE)springer-10.1007/BF00168940 5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins [Elektronische Daten] [Willem Bax, Dicky Van Heuven-Nolsen, Egbert Bos, Maarten Simoons, Pramod Saxena] Summary: The receptors mediating the contractile effect of 5-hydroxytryptamine (5-HT) on the human isolated saphenous vein, obtained from 42 patients undergoing coronary bypass surgery, have been further characterized using a number of 5-HT-related drugs. The rank order of agonist potency was 5-carboxamidotryptamine (5-CT) ≈ 5-HT > methysergide sumatriptan ≈ α-methyl-5-HT ≈ 5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1-Hindolesuccinate (RU 24969) ≈ 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI) > 2-methyl-5-HT > 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT). Flesinoxan was inactive as an agonist. Ketanserin (1 μmol/l) hardly affected sumatriptan-induced contractions but it caused a rightward shift of the upper part of the concentration-response curve of 5-HT and 5-CT. The same concentration of ketanserin caused a parallel rightward shift of the concentration-response curves of α-methyl-5-HT and DOI with pKB values of 7. 1 and 7.1, respectively. The responses to sumatriptan were antagonized by methiothepin (0.1 μmol/l), metergoline (0.1 and 1 μmol/l), rauwolscine (1 μmol/l) and cyanopindolol (1 μmol/l); the calculated pKB values were 7.3, 6.9, 7.3, 6.7 and 6.5, respectively. Contractions to 5-HT were antagonized by methysergide (1 μmol/l), methiothepin (0.1 μmol/l; pKB = 7.1), ICS 205-930 (1 μmol/l; pKB = 5.9) and flesinoxan (30 μmol/l; pKB = 5.3). Remarkably, the contractions elicited by 2-methyl-5-HT were not attenuated by ICS 205-930, but were antagonized by methiothepin (0.1 μmol/l) and, more markedly, by ketanserin (1 μmol/l). There was a high correlation between the functional pD2 values of 5-HT1-like receptor agonists (5-CT, 5-HT, methysergide, sumatriptan, RU 24969 and 8-OH-DPAT) and their reported binding affinities for the 5-HT1D receptor in human or calf brain membranes. Such a correlation for the antagonism of sumatriptan-induced responses was less marked than for the agonists, but of the 5-HT1-like receptor subtypes it was the highest for the 5-HT1D receptor identified in human or calf brain membranes. In 3 patients, undergoing heart transplantation, saphenous vein which had previously functioned as a graft for 6-11 years, was dissected out from the heart. Though the contractions to potassium were significantly smaller in the grafted veins, the pD2 and Emax values (calculated as percentage of potassium-induced contractions) for 5-HT and sumatriptan were similar to those found in the veins obtained directly from the lower leg. It is concluded that contractions in the human isolated saphenous vein induced by 5-HT are mediated by 5-HT2 receptors as well as by a 5-HT1-like receptor resembling the 5-HT1D subtype found in brain membranes. It is also to be noted that 2-methyl-5-HT, considered selective for the 5-HT3 receptor, contracts the saphenous vein mainly via 5-HT2 receptors. Springer-Verlag, 1992 Bypass nationallicence Coronary bypass nationallicence 5-HT receptors nationallicence 5-HT1D receptor nationallicence 5-HT2 receptor nationallicence 5-Hydroxytryptamine nationallicence Human saphenous vein nationallicence Sumatriptan nationallicence Bax Willem Department of Pharmacology, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Post Box 1738, NL-3000 DR, Rotterdam, The Netherlands aut Van Heuven-Nolsen Dicky Department of Pharmacology, Faculty of Pharmacy, University of Utrecht, Post Box 80.082, NL-3508 TB, Utrecht, The Netherlands aut Bos Egbert Thorax Centre, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Post Box 1738, NL-3000 DR, Rotterdam, The Netherlands aut Simoons Maarten Thorax Centre, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Post Box 1738, NL-3000 DR, Rotterdam, The Netherlands aut Saxena Pramod Department of Pharmacology, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Post Box 1738, NL-3000 DR, Rotterdam, The Netherlands aut Naunyn-Schmiedeberg's Archives of Pharmacology Springer-Verlag 345/5(1992-05-01), 500-508 0028-1298 345:5<500 1992 345 210 https://doi.org/10.1007/BF00168940 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF00168940 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Bax Willem Department of Pharmacology, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Post Box 1738, NL-3000 DR, Rotterdam, The Netherlands aut NATIONALLICENCE 700 1- Van Heuven-Nolsen Dicky Department of Pharmacology, Faculty of Pharmacy, University of Utrecht, Post Box 80.082, NL-3508 TB, Utrecht, The Netherlands aut NATIONALLICENCE 700 1- Bos Egbert Thorax Centre, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Post Box 1738, NL-3000 DR, Rotterdam, The Netherlands aut NATIONALLICENCE 700 1- Simoons Maarten Thorax Centre, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Post Box 1738, NL-3000 DR, Rotterdam, The Netherlands aut NATIONALLICENCE 700 1- Saxena Pramod Department of Pharmacology, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, Post Box 1738, NL-3000 DR, Rotterdam, The Netherlands aut NATIONALLICENCE 773 0- Naunyn-Schmiedeberg's Archives of Pharmacology Springer-Verlag 345/5(1992-05-01), 500-508 0028-1298 345:5<500 1992 345 210 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer